Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
Cancer Cell · 2025-02 · 43 (2) · 213-231.e9
DOI: 10.1016/j.ccell.2024.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-02. Verfasst von Shijun Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Genome Institute of Singapore, Agency for Science, Technology, and Research (A(∗)STAR), 60 Biopolis Street, Singapore. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Immunologic Memory, Procollagen-Proline Dioxygenase, Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Agency for Science, Technology and Research, National Medical Research Council.
Abstract (Originalsprache)
Successful immunotherapy relies on both intratumoral and systemic immunity, which is yet to be achieved for most patients with cancer. Here, we identify P4HA1, encoding prolyl 4-hydroxylase 1, as a crucial regulator of CD8+ T cell differentiation strongly upregulated in tumor-draining lymph nodes (TDLNs) and hypoxic tumor microenvironment. P4HA1 accumulates in mitochondria, disrupting the tricarboxylic acid (TCA) cycle through aberrant α-ketoglutarate and succinate metabolism, promoting mitochondria unfitness and exhaustion while suppressing progenitor expansion. Targeting P4HA1 enhances both adoptive and endogenous TCF1+ CD8+ T progenitor expansion while mitigating the development of exhaustion in the tumor, TDLN, and blood, enabling a notable and durable systemic anti-cancer immunity. We propose that P4HA1 induction in CD8+ T cells in cancer orchestrates an immune-escape program, offering a T cell-directed target for system immunotherapy in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genome Institute of Singapore, Agency for Science, Technology, and Research (A(∗)STAR), 60 Biopolis Street, Singapore.
- Department of Oncology, Odense University Hospital and Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
- Singapore Phenome Center, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Institute of Molecular and Cellular Biology, A(∗)STAR, Biopolis, Singapore.
- The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Institute of Molecular and Cellular Biology, A(∗)STAR, Biopolis, Singapore; Department of General Surgery, Tan Tock Seng Hospital and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Förderung
- Agency for Science, Technology and Research
- National Medical Research Council
Zitieren
APA
Ma, S., Ong, L. T., Jiang, Z., Lee, W. C., Lee, P. L., Yusuf, M., Ditzel, H. J., Wang, Y., Chen, Q., Wang, W., Wu, X., Tan, E. Y., & Yu, Q. (2025). Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity. Cancer Cell, 43(2), 213-231.e9. https://doi.org/10.1016/j.ccell.2024.12.001
Vancouver
Ma S, Ong LT, Jiang Z, Lee WC, Lee PL, Yusuf M, et al. Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity. Cancer Cell. 2025;43(2):213-231.e9. doi:10.1016/j.ccell.2024.12.001
BibTeX
@article{Ma2025,
author = {Ma, Shijun and Ong, Li-Teng and Jiang, Zemin and Lee, Wee Chyan and Lee, Puay Leng and Yusuf, Mubaraka and Ditzel, Henrik J and Wang, Yulan and Chen, Qingfeng and Wang, Wenyu and Wu, Xiaojian and Tan, Ern Yu and Yu, Qiang},
title = {Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {2},
pages = {213--231.e9},
doi = {10.1016/j.ccell.2024.12.001}
}
EUVIMED